东方生物 (688298)

Zhejiang Orient Gene Biotech Co., Ltd.

KSH

K-Line Chart

No K-line data available

Company NameZhejiang Orient Gene Biotech Co., Ltd.
Listing Date2020-02-05
Issue Price21.25RMB
Registered Capital2016010k RMB
Legal RepresentativeFang Jianqiu
Registered AddressNo. 3787, East Section of Yangguang Avenue, Dipu Street, Anji County, Huzhou City, Zhejiang Province, China
IndustryMedical Devices
Main BusinessSpecializing in the R&D, production, and sales of in vitro diagnostic products, forming a business structure dominated by POCT rapid diagnostic reagents, with a focus on developing products such as molecular diagnostics, biological raw materials, diagnostic instruments, and liquid biochips.
Company ProfileZhejiang Orient Gene Biotech Co., Ltd. has not only established an enterprise technology R&D center (recognized as a provincial high-tech enterprise R&D center in 2014) and hired high-tech talents with competitive salaries, but has also collaborated with domestic and international research institutions and universities such as Zhejiang University and the Zhejiang Provincial Key Laboratory of Biotherapy to ensure technological support for the company. Currently, the company's products are widely used in various fields including rapid diagnosis of infectious diseases, reproductive medicine diagnostics, drug testing, and tumor genetic testing. They feature technical characteristics such as good repeatability and specificity, high sensitivity, and ease of operation. The products are exported to international markets including the United States, Europe, Africa, the Middle East, Asia, South America, and South Asia. The company has also undertaken research projects such as the National Torch Program Project of the Ministry of Science and Technology, the Provincial Industrial Transformation and Upgrading Program, and the Huzhou South Taihu Elite Program.

Stock Details

1. Key Indicators

  • Total Shares(W): 734059.07
  • Circulating A-Shares(W): 734059.07
  • Earnings Per Share(RMB): 1.23
  • Net Assets Per Share(RMB): 5.67
  • Operating Revenue(W RMB): 1345261.60
  • Total Profit(W RMB): 1345261.60
  • **Net Profit Attributable to Parent(W RMB) **: 1345261.60
  • Net Profit Growth Rate(%): -55.89
  • Weighted Return on Equity(%): 4.6500
  • Operating Cash Flow Per Share(RMB): 1.23
  • Undistributed Profit Per Share(RMB): 1.23
  • Capital Reserve Per Share(RMB): 1.23

2. Main Business

The main business covers:

  • New energy vehicle manufacturing and sales
  • Intelligent transportation system R&D
  • Fuel cell technology development
  • Autonomous driving solutions

3. Company Basic Information

  • Company Name: Dongfeng Motor Corporation Limited
  • Listing Date: 2001-05-18
  • Industry: Automobile Manufacturing
  • Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
  • Website: https://www.dongfeng.com.cn/
  • Company Profile: The company was established in 1998 with Beijing Capital Venture Group as the main sponsor. It is a large enterprise focusing on automobile manufacturing, dedicated to the research, development, and promotion of new energy vehicles and intelligent transportation technologies.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Securities Finance Co., Ltd. National Team 5,000 10.2
2 China Asset Management Co., Ltd. Public Fund 3,200 6.5
3 Hillhouse Capital Management, Ltd. Private Equity Fund 2,800 5.7
4 National Social Security Fund National Team 2,500 5.1
5 E Fund Management Co., Ltd. Public Fund 2,000 4.1
6 China Universal Asset Management Co., Ltd. Public Fund 1,800 3.7
7 CITIC Securities Co., Ltd. Broker 1,500 3.1
8 Guotai Junan Securities Co., Ltd. Broker 1,200 2.4
9 China Merchants Bank Co., Ltd. Bank 1,000 2.0
10 ICBC Credit Suisse Asset Management Co., Ltd. Public Fund 900 1.8

5. Concept Sectors

  • Carbon Neutrality
  • Intelligent Transportation
  • Fuel Cell
  • Autonomous Driving
  • New Energy Vehicles
  • Hydrogen Energy
  • Huawei Auto
  • Internet of Vehicles (IoV)

Remarks

  • Data update date: 2025-11-02
  • Data source: Public Market Information